Results 251 to 260 of about 899,795 (311)
Some of the next articles are maybe not open access.

Related searches:

Contrast agents for MRI

Basic Research in Cardiology, 2008
Molecular imaging is a rapidly growing field with the potential to revolutionize cardiovascular medicine by shifting diagnostic focus from functional abnormalities which occur late in a disease process to the biochemical events which precipitate the earliest stages of disease.
Emily A, Waters, Samuel A, Wickline
openaire   +2 more sources

CONTRAST AGENTS IN NEUROIMAGING

Neuroimaging Clinics of North America, 1994
Until there is total elimination of adverse reactions and side effects with contrast agents, there will continue to be a need for improvement. The ideal contrast agent should be efficacious, safe, water soluble, with chemical and heat stability, biologically inert, with low viscosity, with osmolality the same as human serum, with selective excretion by
S E, Byrd, C F, Darling, E, Allen
openaire   +2 more sources

Contrast agents and mechanisms

Drug Discovery Today: Technologies, 2011
MRI contrast agents are routinely used in clinical settings. Important advances in their design have been attained in the past few years to overcome sensitivity issues and to make possible molecular imaging applications by means of this modality. Besides the sensitivity enhancement of paramagnetic relaxation probes, outstanding results have been ...
Dastrú Walter   +2 more
openaire   +3 more sources

Contrast agent nephrotoxicity: comparison of ionic and nonionic contrast agents

American Journal of Roentgenology, 1987
The effects on glomerular and proximal tubular function of an ionic contrast agent (sodium meglumine diatrizoate) and a nonionic agent (iopamidol) were compared in 34 patients with normal renal function. The patients received large doses (2.5 ml/kg body weight) of contrast material for IV digital subtraction angiography. Urine samples, collected before,
STACUL F   +5 more
openaire   +3 more sources

Contrast Agents

Veterinary Clinics of North America: Small Animal Practice, 1993
Pharmacologic development and clinical use of nonionic low osmolality contrast agents have lowered incidences of contrast reactions. Exclusive use of these agents may be limited owing to their high costs. Ionic high osmolality agents still provide reliable means of positive contrast enhancement, and minimal problems with reactions have been experienced
openaire   +2 more sources

Contrast Agents in diagnostic ultrasound

Ultrasound in Medicine & Biology, 1989
We review the field of contrast agents in diagnostic ultrasound. The progress in the development of various classes of contrast agents such as free and encapsulated gas bubbles, colloidal suspensions, emulsions, and aqueous solutions is described. The mechanisms for production of backscatter contrast, as well as attenuation contrast and speed of sound ...
J, Ophir, K J, Parker
openaire   +3 more sources

Magnetoliposomes as Contrast Agents

2003
Publisher Summary Liposomes are entirely biocompatible and are recognized as promising microvehicles for therapeutics and diagnostics in vivo and host either polar drugs in their aqueous inner space or lipophilic drugs in the lipid bilayer, protecting the entrapped pharmaceuticals from potential inactivation by external factors and without ...
Jeff W, Bulte, Marcel, De Cuyper
openaire   +2 more sources

Home - About - Disclaimer - Privacy